HER2 and response to paclitaxel in node-positive breast cancer

N Engl J Med. 2008 Jan 10;358(2):197; author reply 198. doi: 10.1056/NEJMc073152.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antibodies, Monoclonal / administration & dosage*
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents, Phytogenic / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Chemotherapy, Adjuvant
  • Female
  • Humans
  • Paclitaxel / administration & dosage*
  • Receptor, ErbB-2 / analysis*
  • Receptors, Estrogen / analysis
  • Trastuzumab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents, Phytogenic
  • Receptors, Estrogen
  • Receptor, ErbB-2
  • Trastuzumab
  • Paclitaxel